Plain-English translation of NCT06532539 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a new combination approach can work better for women whose endometrial cancer has come back or spread to a small number of places after their first treatment. The combination includes (an immunotherapy drug that helps your body fight cancer), two chemotherapy drugs (), and radiation therapy directed at the cancer sites. The goal is to see if this medication, combined with chemotherapy and radiation, can improve survival and response rates while being safe and manageable.
Endometrial cancer that returns after initial treatment is difficult to manage, and current standard approaches don't work well for all patients. This trial exists to see whether adding this new immune-boosting medication to chemotherapy and radiation can offer a better chance of controlling the cancer and improving survival outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive the medication , two chemotherapy drugs, and radiation therapy according to a set schedule at a hospital or cancer center. You'll have regular clinic visits for check-ups, blood tests, and imaging scans to see how well the treatment is working and to monitor for any side effects. You'll also provide blood and tissue samples so researchers can learn which patients benefit most from this treatment combination.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China